Tempo Scan Pacific Tbk PT
IDX:TSPC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 750
2 840
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tempo Scan Pacific Tbk PT
Other Current Liabilities
Tempo Scan Pacific Tbk PT
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Current Liabilities
Rp499.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
29%
|
CAGR 10-Years
12%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Current Liabilities
Rp954.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Current Liabilities
Rp83.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
28%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Current Liabilities
Rp94.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Current Liabilities
Rp117.9B
|
CAGR 3-Years
49%
|
CAGR 5-Years
101%
|
CAGR 10-Years
42%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Current Liabilities
Rp342.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
Tempo Scan Pacific Tbk PT
Glance View
PT Tempo Scan Pacific Tbk engages in the pharmaceutical business. The company is headquartered in Jakarta, Dki Jakarta and currently employs 4,725 full-time employees. The firm has three core business divisions: pharmaceutical division, consumer products and cosmetics division and distribution division. Its pharmaceutical division manufactures and markets various over-the-counter (OTC) and ethical drugs as well as supplements. Its manufacturing plants are located in Bekasi, Indonesia. Its consumer products and cosmetics division manufactures and markets various consumer products, such as soap, household products and cosmetics. Its manufacturing plants are located in Pulogadung, Bekasi and Surabaya, Indonesia. Its distribution division distributes its products and third-party products. Its subsidiaries include PT Supra Ferbindo, PT Tempo Rx Farma, PT Tempo Nagadi, PT Rudy Soetadi, PT Perusahaan Dagang Tempo and PT Supra Usadhatama.
See Also
What is Tempo Scan Pacific Tbk PT's Other Current Liabilities?
Other Current Liabilities
499.6B
IDR
Based on the financial report for Sep 30, 2024, Tempo Scan Pacific Tbk PT's Other Current Liabilities amounts to 499.6B IDR.
What is Tempo Scan Pacific Tbk PT's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
12%
Over the last year, the Other Current Liabilities growth was 6%. The average annual Other Current Liabilities growth rates for Tempo Scan Pacific Tbk PT have been 13% over the past three years , 29% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
